Recently Featured

Injectable Microgel Developed to Reduce Bleeding in Infants Undergoing Surgery

April 17, 2026
Biomedical researchers at the Lampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill/North Carolina State University, have developed an injectable microgel designed to significantly reduce bleeding in infants undergoing surgical procedures. In animal model tests, these hemostatic microgels, termed B-knob-triggered microgels (BK-TriGs), demonstrated a reduction in bleeding by at least 50%.…

Epigenetic Strategy Restores Tumor Suppressor in Acute Myeloid Leukemia Models

April 17, 2026
Scientists from The Jackson Laboratory (JAX) and collaborators have uncovered a novel approach to treating acute myeloid leukemia (AML) by reactivating a critical tumor suppressor gene. Their findings, published in Science Translational Medicine, suggest that this strategy could provide an alternative to conventional chemotherapy, which often comes with severe side effects. The study emphasizes the…

FDA Issues Boxed Warning for Glatiramer Acetate Due to Anaphylaxis Risk

April 17, 2026
The U.S. Food and Drug Administration (FDA) has introduced a Boxed Warning for glatiramer acetate, marketed as Copaxone and Glatopa, highlighting the potential for a rare but serious allergic reaction known as anaphylaxis. This regulatory action underscores the importance of monitoring patients closely for symptoms following administration of the medication, which is commonly prescribed for…

Trump Revives Pharma Tariffs with 100% Charges, But Leaves Loopholes

April 16, 2026
The recent reinstatement of 100% tariffs on certain pharmaceutical imports by the Trump administration under “Section 232” has raised significant concerns within the industry. However, analysts suggest that these tariffs will not apply to a broad spectrum of drugs, which may mitigate the overall impact on the sector. This selective application indicates that while the…

Ongoing Cases